Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: January 13, 2010
Last updated: September 18, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 18, 2012